<DOC>
	<DOCNO>NCT00795574</DOCNO>
	<brief_summary>A study ass safety efficacy IV drug infliximab treatment hidradenitis suppurativa</brief_summary>
	<brief_title>Study Assess Safety Efficacy Infliximab Treat Hidradenitis Suppurtativa</brief_title>
	<detailed_description />
	<mesh_term>Hidradenitis</mesh_term>
	<mesh_term>Hidradenitis Suppurativa</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Person must moderate severe Hidradenitis suppurativa Multiple ER doctor visit relate HS Intralesional kenalog injection &gt; 5/year , none within 3 month entry HS &gt; 1 year duration Failed systemic retinoids , within 3 month entry Failed least one prior course antibiotic therapy , must administer within 3 month entry study ( exclude recommend antibiotic regimen give immediately randomization evidence active infection History surgery ( reconstructive ) , within 3 month entry Women pregnant , nursing , plan pregnancy within 6 month last infusion ( include father 's plan father child within 6 month last infusion Known allergy infliximab Use systemic antiinflammatory medication except NSAIDs low dose systemic steroid ( equal less 10 mg daily prednisolone equivalent ) . Have previous treatment monoclonal antibody antibody fragment . Have know history serious infection ( eg , hepatitis , pneumonia pyelonephritis ) previous 3 month . Have opportunistic infection ( eg , herpes zoster [ shingle ] , cytomegalovirus , Pneumocystis carinii , aspergillosis , histoplasmosis , mycobacteria TB ) within 6 month prior screen . Are consider ineligible accord TB eligibility assessment , screening , early detection reactivation rule define Section 26 : Tuberculosis Eligibility Assessment , Screening , Early Detection Reactivation Rules . Have history lymphoproliferative disease , include lymphoma sign suggestive possible lymphoproliferative disease lymphadenopathy unusual size location ( eg , node posterior triangle neck , infraclavicular , epitrochlear , periaortic area ) , splenomegaly . Currently know malignancy history malignancy within previous 5 year , exception basal cell squamous cell carcinoma skin fully excise evidence recurrence . Have current sign symptom severe , progressive uncontrolled renal , hepatic , hematologic , gastrointestinal , endocrine , pulmonary , cardiac , neurologic , cerebral disease .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Hidradenitis Suppurativa</keyword>
</DOC>